Appeals Court Upholds DNA Testing of Felony Suspects
By Carol J. Williams,
Los Angeles Times
| 02. 24. 2012
Law enforcement officers may take a DNA sample from anyone arrested on a felony charge without running afoul of the suspect's right to be free from unreasonable search and seizure, a divided federal appeals court ruled Thursday.
The challenge brought by a group of Californians arrested for alleged felonies but never convicted upheld a 2004 amendment to the state's laws governing DNA collection and use.
In a 2-1 ruling, a panel of the U.S. 9th Circuit Court of Appeals compared taking an oral swab from a suspect with fingerprinting arrestees, a decades-old booking practice consistently upheld by the courts as a legitimate identification aid.
"We assess the constitutionality of the 2004 amendment by considering the 'totality of the circumstances,' balancing the arrestees' privacy interests against the government's need for the DNA samples," said the opinion written by Judge Milan D. Smith Jr.
"DNA analysis is an extraordinarily effective tool for law enforcement officials to identify arrestees, solve past crimes, and exonerate innocent suspects," wrote Smith, who was named to the court by President George W. Bush, in an opinion...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...